Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Advances in malignant melanoma

Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany
Advances in malignant melanoma ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )
11 Nov 2016

What involvement do stem cells have in disease and resistance?

Prof Andreas Trumpp - German Cancer Research Center, Heidelberg, Germany
What involvement do stem cells have in disease and resistance? ( Prof Andreas Trumpp - German Cancer Research Center, Heidelberg, Germany )
11 Nov 2016

How does the protein kinase Akt enable tumours to grow?

Dr Igor Vivanco - The Institute of Cancer Research, London, UK
How does the protein kinase Akt enable tumours to grow? ( Dr Igor Vivanco - The Institute of Cancer Research, London, UK )
11 Nov 2016

Using adoptive cell therapy to fight cancer

Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA
Using adoptive cell therapy to fight cancer ( Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA )
11 Nov 2016

History and progress of CD38 in myeloma

Dr Fabio Malavasi - University of Turin, Turin, Italy
History and progress of CD38 in myeloma ( Dr Fabio Malavasi - University of Turin, Turin, Italy )
2 Nov 2016

History of antiangiogenic drugs in multiple myeloma, starting with thalidomide

Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide ( Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany )
2 Nov 2016

Drug combos with daratumumab likely to become standard of care in myeloma

Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland
Drug combos with daratumumab likely to become standard of care in myeloma ( Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland )
1 Nov 2016

New drugs and combinations in haematological cancers improve complete remission rates

Dr Paolo Corradini - University of Milan, Milan, Italy
New drugs and combinations in haematological cancers improve complete remission rates ( Dr Paolo Corradini - University of Milan, Milan, Italy )
1 Nov 2016

CDK clinical trial results, benefit, side effects and costs

Dr Pierfranco Conte - Instituto Oncologico Veneto, Padua, Italy
CDK clinical trial results, benefit, side effects and costs ( Dr Pierfranco Conte - Instituto Oncologico Veneto, Padua, Italy )
26 Oct 2016

Extending indication of CDK 4/6 inhibitors in the adjuvant and neoadjuvant setting

Dr Sara Hurvitz - UCLA Medical Center, Santa Monica, USA
Extending indication of CDK 4/6 inhibitors in the adjuvant and neoadjuvant setting ( Dr Sara Hurvitz - UCLA Medical Center, Santa Monica, USA )
26 Oct 2016

Current indications for CDK 4/6 inhibitors (plus antiestrogen), biomarkers

Dr Sibylle Loibl - German Breast Cancer Group
Current indications for CDK 4/6 inhibitors (plus antiestrogen), biomarkers ( Dr Sibylle Loibl - German Breast Cancer Group )
26 Oct 2016

Coming of age for CDK 4/6 inhibitors: Interactive session and close

Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy
Coming of age for CDK 4/6 inhibitors: Interactive session and close ( Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy )
26 Oct 2016